AAPL333.08+0.81 (+0.24%) ▲|ABBV261.77+4.65 (+1.81%) ▲|ABT103.09+1.14 (+1.12%) ▲|ACN195.00+11.10 (+6.04%) ▲|ADBE265.60+13.37 (+5.30%) ▲|AMAT424.21-32.28 (-7.07%) ▼|AMD493.41-22.72 (-4.40%) ▼|AMGN381.50+4.15 (+1.10%) ▲|AMT176.94-0.91 (-0.51%) ▼|AMZN253.54-3.24 (-1.26%) ▼|AVGO344.72-17.27 (-4.77%) ▼|AXP327.78+3.09 (+0.95%) ▲|BA210.27-0.18 (-0.09%) ▼|BAC59.47-3.22 (-5.14%) ▼|BKNG175.35+1.43 (+0.82%) ▲|BLK1,065.60-14.05 (-1.30%) ▼|BMY64.10+0.46 (+0.72%) ▲|BNY157.66-5.00 (-3.07%) ▼|BRK-B514.95+4.58 (+0.90%) ▲|C136.18-2.64 (-1.90%) ▼|CAT784.00-34.57 (-4.22%) ▼|CL87.89+1.09 (+1.26%) ▲|CMCSA24.88-0.32 (-1.27%) ▼|COF206.68-1.62 (-0.78%) ▼|COP136.67-0.68 (-0.50%) ▼|COST918.91+14.14 (+1.56%) ▲|CRM259.43+11.71 (+4.73%) ▲|CSCO110.06-2.07 (-1.85%) ▼|CVS95.55+0.89 (+0.94%) ▲|CVX212.17-1.89 (-0.88%) ▼|DE681.46+5.72 (+0.85%) ▲|DHR203.25+3.11 (+1.55%) ▲|DIS108.59+2.04 (+1.91%) ▲|DUK119.02-0.40 (-0.34%) ▼|EMR148.30-3.89 (-2.56%) ▼|FDX312.57+1.80 (+0.58%) ▲|GD356.81+0.91 (+0.26%) ▲|GE317.56-6.10 (-1.88%) ▼|GEV874.76-82.51 (-8.62%) ▼|GILD146.41+2.69 (+1.87%) ▲|GM87.16+1.54 (+1.80%) ▲|GOOG345.71+10.26 (+3.06%) ▲|GOOGL349.39+10.89 (+3.22%) ▲|GS988.45-40.73 (-3.96%) ▼|HD310.87+2.13 (+0.69%) ▲|HON201.38-0.98 (-0.48%) ▼|IBM249.09+5.80 (+2.38%) ▲|INTC97.19-5.75 (-5.59%) ▼|INTU339.15+17.58 (+5.47%) ▲|ISRG377.94+8.79 (+2.38%) ▲|JNJ266.32+0.74 (+0.28%) ▲|JPM350.13-6.10 (-1.71%) ▼|KO89.35+1.06 (+1.20%) ▲|LIN464.41-1.81 (-0.39%) ▼|LLY1,138.28+22.58 (+2.02%) ▲|LMT529.38+5.19 (+0.99%) ▲|LOW198.17+1.35 (+0.69%) ▲|LRCX273.49-24.73 (-8.29%) ▼|MA574.42+5.23 (+0.92%) ▲|MCD257.49+4.96 (+1.96%) ▲|MDLZ62.39-0.05 (-0.08%) ▼|MDT93.80+2.84 (+3.12%) ▲|META665.60+17.57 (+2.71%) ▲|MMM162.02-2.95 (-1.79%) ▼|MO70.61+1.63 (+2.36%) ▲|MRK144.85+0.92 (+0.64%) ▲|MS206.58-7.80 (-3.64%) ▼|MSFT505.41+9.78 (+1.97%) ▲|MU924.03-51.23 (-5.25%) ▼|NEE81.63-0.68 (-0.83%) ▼|NFLX80.32+2.92 (+3.77%) ▲|NKE37.05+0.25 (+0.68%) ▲|NOW142.35+9.82 (+7.41%) ▲|NVDA210.96-7.33 (-3.36%) ▼|ORCL144.79-5.49 (-3.65%) ▼|PEP136.34+0.02 (+0.01%) ▲|PFE27.72+0.00 (+0.00%) ▲|PG146.13+0.86 (+0.59%) ▲|PLTR173.31+6.08 (+3.64%) ▲|PM194.86+3.80 (+1.99%) ▲|QCOM180.15-1.82 (-1.00%) ▼|RTX195.34-2.34 (-1.18%) ▼|SBUX99.07+0.33 (+0.33%) ▲|SCHW107.31+0.06 (+0.06%) ▲|SO87.00-0.17 (-0.20%) ▼|SPG204.97+0.14 (+0.07%) ▲|T26.51+0.45 (+1.73%) ▲|TMO613.62+3.80 (+0.62%) ▲|TMUS182.90+0.57 (+0.31%) ▲|TSLA358.97-6.47 (-1.77%) ▼|TXN263.42-5.28 (-1.97%) ▼|UBER72.63+0.96 (+1.34%) ▲|UNH383.55+6.78 (+1.80%) ▲|UNP285.08+0.68 (+0.24%) ▲|UPS102.46+2.18 (+2.17%) ▲|USB62.68-0.16 (-0.25%) ▼|V375.28+4.83 (+1.30%) ▲|VZ51.29+0.68 (+1.34%) ▲|WFC88.71-1.58 (-1.75%) ▼|WMT109.08+1.93 (+1.80%) ▲|XOM165.08-0.91 (-0.55%) ▼|AAPL333.08+0.81 (+0.24%) ▲|ABBV261.77+4.65 (+1.81%) ▲|ABT103.09+1.14 (+1.12%) ▲|ACN195.00+11.10 (+6.04%) ▲|ADBE265.60+13.37 (+5.30%) ▲|AMAT424.21-32.28 (-7.07%) ▼|AMD493.41-22.72 (-4.40%) ▼|AMGN381.50+4.15 (+1.10%) ▲|AMT176.94-0.91 (-0.51%) ▼|AMZN253.54-3.24 (-1.26%) ▼|AVGO344.72-17.27 (-4.77%) ▼|AXP327.78+3.09 (+0.95%) ▲|BA210.27-0.18 (-0.09%) ▼|BAC59.47-3.22 (-5.14%) ▼|BKNG175.35+1.43 (+0.82%) ▲|BLK1,065.60-14.05 (-1.30%) ▼|BMY64.10+0.46 (+0.72%) ▲|BNY157.66-5.00 (-3.07%) ▼|BRK-B514.95+4.58 (+0.90%) ▲|C136.18-2.64 (-1.90%) ▼|CAT784.00-34.57 (-4.22%) ▼|CL87.89+1.09 (+1.26%) ▲|CMCSA24.88-0.32 (-1.27%) ▼|COF206.68-1.62 (-0.78%) ▼|COP136.67-0.68 (-0.50%) ▼|COST918.91+14.14 (+1.56%) ▲|CRM259.43+11.71 (+4.73%) ▲|CSCO110.06-2.07 (-1.85%) ▼|CVS95.55+0.89 (+0.94%) ▲|CVX212.17-1.89 (-0.88%) ▼|DE681.46+5.72 (+0.85%) ▲|DHR203.25+3.11 (+1.55%) ▲|DIS108.59+2.04 (+1.91%) ▲|DUK119.02-0.40 (-0.34%) ▼|EMR148.30-3.89 (-2.56%) ▼|FDX312.57+1.80 (+0.58%) ▲|GD356.81+0.91 (+0.26%) ▲|GE317.56-6.10 (-1.88%) ▼|GEV874.76-82.51 (-8.62%) ▼|GILD146.41+2.69 (+1.87%) ▲|GM87.16+1.54 (+1.80%) ▲|GOOG345.71+10.26 (+3.06%) ▲|GOOGL349.39+10.89 (+3.22%) ▲|GS988.45-40.73 (-3.96%) ▼|HD310.87+2.13 (+0.69%) ▲|HON201.38-0.98 (-0.48%) ▼|IBM249.09+5.80 (+2.38%) ▲|INTC97.19-5.75 (-5.59%) ▼|INTU339.15+17.58 (+5.47%) ▲|ISRG377.94+8.79 (+2.38%) ▲|JNJ266.32+0.74 (+0.28%) ▲|JPM350.13-6.10 (-1.71%) ▼|KO89.35+1.06 (+1.20%) ▲|LIN464.41-1.81 (-0.39%) ▼|LLY1,138.28+22.58 (+2.02%) ▲|LMT529.38+5.19 (+0.99%) ▲|LOW198.17+1.35 (+0.69%) ▲|LRCX273.49-24.73 (-8.29%) ▼|MA574.42+5.23 (+0.92%) ▲|MCD257.49+4.96 (+1.96%) ▲|MDLZ62.39-0.05 (-0.08%) ▼|MDT93.80+2.84 (+3.12%) ▲|META665.60+17.57 (+2.71%) ▲|MMM162.02-2.95 (-1.79%) ▼|MO70.61+1.63 (+2.36%) ▲|MRK144.85+0.92 (+0.64%) ▲|MS206.58-7.80 (-3.64%) ▼|MSFT505.41+9.78 (+1.97%) ▲|MU924.03-51.23 (-5.25%) ▼|NEE81.63-0.68 (-0.83%) ▼|NFLX80.32+2.92 (+3.77%) ▲|NKE37.05+0.25 (+0.68%) ▲|NOW142.35+9.82 (+7.41%) ▲|NVDA210.96-7.33 (-3.36%) ▼|ORCL144.79-5.49 (-3.65%) ▼|PEP136.34+0.02 (+0.01%) ▲|PFE27.72+0.00 (+0.00%) ▲|PG146.13+0.86 (+0.59%) ▲|PLTR173.31+6.08 (+3.64%) ▲|PM194.86+3.80 (+1.99%) ▲|QCOM180.15-1.82 (-1.00%) ▼|RTX195.34-2.34 (-1.18%) ▼|SBUX99.07+0.33 (+0.33%) ▲|SCHW107.31+0.06 (+0.06%) ▲|SO87.00-0.17 (-0.20%) ▼|SPG204.97+0.14 (+0.07%) ▲|T26.51+0.45 (+1.73%) ▲|TMO613.62+3.80 (+0.62%) ▲|TMUS182.90+0.57 (+0.31%) ▲|TSLA358.97-6.47 (-1.77%) ▼|TXN263.42-5.28 (-1.97%) ▼|UBER72.63+0.96 (+1.34%) ▲|UNH383.55+6.78 (+1.80%) ▲|UNP285.08+0.68 (+0.24%) ▲|UPS102.46+2.18 (+2.17%) ▲|USB62.68-0.16 (-0.25%) ▼|V375.28+4.83 (+1.30%) ▲|VZ51.29+0.68 (+1.34%) ▲|WFC88.71-1.58 (-1.75%) ▼|WMT109.08+1.93 (+1.80%) ▲|XOM165.08-0.91 (-0.55%) ▼|
18.5 C
New York
Tuesday, September 15, 2026

Tag: launch

GPCR-Targeting Therapies Market Poised for Strong Growth During the Forecast Period (2025-2034) Across 7MM Due to the Rising Cancer Diagnoses and Drug Pipeline Expansion...

The GPCR-targeting therapies market is expected to grow significantly in the coming years. This is due to the increasing number of patients who are...

Allbirds Announces Financing Strategy to Support Growth Plans

Strengthens Financial Position with Expanded Credit Facility and Flexibility for Future Strategic Equity Sales
Strengthens Financial Position with Expanded Credit Facility and Flexibility for Future Strategic Equity Sales

Autel U.S. Announces Scholarships for Automotive Repair Students

PORT WASHINGTON, N.Y., June 30, 2025 /PRNewswire/ -- Autel, a leading developer, manufacturer, and distributor of professional automotive diagnostic tools and equipment, is proud to announce...

Mission Produce® Appoints Laura Flanagan to Board of Directors

OXNARD, Calif., June 30, 2025 (GLOBE NEWSWIRE) -- Mission Produce, Inc. (NASDAQ: AVO) (“Mission” or “the Company”), a world leader in sourcing, producing, and distributing fresh Hass avocados, today announced the appointment of Laura Flanagan to its board of directors, effective June 30, 2025. Flanagan is appointed as an independent Class III director with a term expiring at the Company’s 2026 Annual Meeting of Stockholders. In connection with this appointment, Mission Produce’s board of directors has increased the size of the board from nine to ten directors.

CASAMIGOS TEQUILA ELEVATES THE CANNED COCKTAILS GAME WITH NEW CASAMIGOS MARGARITAS

THE AWARD-WINNING BRAND BRINGS SMOOTH SIPS WITH READY-TO-DRINK ANYTIME, ANYWHERE MARGARITA NEW YORK, June 30, 2025 /PRNewswire/ -- Casamigos, the award-winning tequila brand, announced today...

DRML Miner Launches Zero-Cost USDT Cloud Mining Platform with Daily Payouts and Referral Bonuses

Experience Effortless Crypto Earnings with DRML Miner
Experience Effortless Crypto Earnings with DRML Miner

Florida Chamber of Commerce Appoints John Doolittle to Lead Health Council; Florida Chamber Leadership Cabinet Launches Mental Wellness Institute to Improve Behavioral Health for...

TALLAHASSEE, Fla., June 30, 2025 /PRNewswire/ -- The Florida Chamber Leadership Cabinet on Safety, Health, and Sustainability—the Chamber's entity guiding statewide efforts to improve workplace...

Introducing the Annual Ben Oberto Memorial Scholarship: Honoring a Larger-than-Life Champion of Piedmont Wines

Somm.ai, the Consorzio di Tutela Barolo Barbaresco Alba Langhe e Dogliani, and Colangelo & Partners join together to honor Ben Oberto's legacy through a...

The Inner Circle acknowledges, Kristina Gray, MBA as an Inner Circle Lifetime member

PEARLAND, Texas, June 30, 2025 /PRNewswire/ -- Prominently featured in The Inner Circle, Kristina Gray, MBA is acknowledged as an Inner Circle Lifetime for...

Agooran Launches Strongly on Plouton Exchange, Incredible Short-Term Growth as Medical Technology Sector Experiences Strategic Surge

New York, NY, June 30, 2025 (GLOBE NEWSWIRE) -- The global medical technology sector is witnessing a phase of explosive growth. Recently, the flagship global digital healthcare project Agooran (AOO) officially launched on Plouton Exchange. After its launch, the market performance has been exceptionally strong, with a price increase of over 15 times in a short period and trading volume hitting new highs within 24 hours, making it one of the standout emerging technology asset projects of the year. This event signifies that the assetization of global medical data is entering the mainstream and accelerating its implementation supported by blockchain infrastructure.



https://www.fincen.gov/msb-state-selector

Agooran is one of the few medical technology digital platform projects that achieves a triad of "technological closure + compliance model + commercial landing." The project aims to promote the assetization of global life data, deployment of AI intelligent diagnostic models, health behavior incentives, and integration of intelligent insurance payment systems. Its core architecture is the self-developed ALS (Agooran Life-System) intelligent life framework, which supports the entire process of assetization logic, from individual health data rights confirmation and cross-institutional research collaboration to intelligent insurance repricing.



Plouton Exchange, where Agooran has launched, is a globally compliant digital asset trading platform registered in the U.S. and headquartered in Silicon Valley, California. It has obtained the U.S. MSB financial services license and completed compliance registrations in Singapore, Lithuania, the UAE, and other regions. Plouton Exchange has long been characterized by its core strengths in "global compliance + technological security," providing institutional-grade custody systems, KYC/AML identification systems, fiat deposit services, and high-performance matching engines, making it one of the most trusted primary trading platforms for international capital.



The project's performance has garnered widespread market attention, with several leading research institutions issuing positive signals. A well-known investment bank noted in an internal briefing: "Agooran's ALS architecture is currently the most logically sound and data-secure medical technology system, particularly suited to address structural challenges such as the fragmentation of traditional healthcare, data non-circulation, and scarcity of research samples."

According to publicly available market data, the global healthcare industry has surpassed a total scale of one trillion dollars, with sectors related to data governance, cross-border research collaboration, and medical AI decision support systems becoming core growth points in emerging markets. Currently, healthcare data assets have not been fully confirmed and circulated, with over 80% of data remaining "dormant," which presents a key entry point for Agooran (AOO) to provide infrastructure support.



Agooran has attracted attention from several international capital sources, including notable investment institutions in the U.S. and Europe that are involved in the intersection of medical technology and Web3. The project team consists of former executives from top global medical schools, members of European AI laboratories, and EU medical data compliance advisors, possessing global governance capabilities and cross-policy implementation skills.



After launching on Plouton Exchange, Agooran (AOO) quickly garnered significant attention from numerous users and institutions, with its token's circulating market value rapidly increasing and broad participation enhancing community and social media engagement. The market generally anticipates that Agooran's medium- to long-term potential is still severely underestimated, and as the ecosystem gradually takes shape and nodes are deployed, its token value has substantial room for further growth.



As a bridge connecting traditional healthcare systems with new digital asset models, Agooran represents not just technological innovation, but a fundamental reconstruction of global public health governance logic. Plouton Exchange, with its robust compliance support system and global infrastructure, provides a solid guarantee for the successful implementation of this transformative project.



Media Contact

Contact: David D. Belle

Company Name: Agooran

Website: https://agooran.com/

Email: David.Belle@agooran.com

Contact: William C. Denton

Company Name: Plouton Ltd

Website: https://trade.ploutoning.net

Email: William@ploutoning.net

Disclaimer: The information provided in this press release is not a solicitation for investment, nor is it intended as investment advice, financial advice, or trading advice. It is strongly recommended you practice due diligence, including consultation with a professional financial advisor, before investing in or trading cryptocurrency and securities.

CustomerInsights.AI (CIAI) Launches ciATHENA: A Conversational, Agentic AI Platform Redefining Pharma Commercial Analytics

PHOENIX, June 30, 2025 /PRNewswire/ -- Last week CIAI announced the launch of ciATHENA, a next generation Agentic AI platform built to accelerate commercial...

NORTH.CLOUD SECURES $5M AND LAUNCHES NEW OPERATING SYSTEM FOR ADVANCED CLOUD OPTIMIZATION AND MANAGEMENT

Funding Powers Industry-First FinOps for Smarter, More Sustainable Cloud Management NEW YORK, June 30, 2025 /PRNewswire/ -- North.Cloud has successfully closed its Series A funding round,...

Merrell Advances Running Innovation with the Launch of the High-Tech ProMorph Hybrid

Engineered for runners who move between roads and trails, the ProMorph blends responsive foam and all-terrain traction ROCKFORD, Mich., June 30, 2025 /PRNewswire/ -- Merrell,...

Southbrook Organic Vineyards celebrates regenerative farming with the launch of its mini-documentary “Ode to Niagara”, featuring globally acclaimed Canadian Chef Keith Pears

Southbrook debuts Ode to Niagara, a mini-doc celebrating regenerative farming, local terroir, and guest Chef Keith Pears at July 6 event.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsLaunch